Protalix BioTherapeutics ...

AMEX: PLX · Real-Time Price · USD
1.48
-0.04 (-2.63%)
At close: Aug 15, 2025, 3:59 PM
1.50
1.35%
After-hours: Aug 15, 2025, 05:59 PM EDT

Protalix BioTherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
19.76M 23.63M 17.11M 38.98M
Short-Term Investments
15.07M 20.93M 5.07M 38.98M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
462K 528K 1.27M 2.08M
Receivables
2.91M 5.27M 4.59M 3.44M
Inventory
21.24M 19.05M 16.8M 17.95M
Other Current Assets
596K 611K 536K 380K
Total Current Assets
60.08M 69.93M 44.88M 61.67M
Property-Plant & Equipment
10.02M 10.88M 9.64M 9.92M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
13.34M 14.5M 10.91M 12M
Total Assets
73.42M 84.43M 55.79M 73.67M
Account Payables
4.53M 4.32M 5.86M 6.99M
Deferred Revenue
n/a n/a 13.18M 8.55M
Short-Term Debt
n/a 21.66M 1.12M 1.21M
Other Current Liabilities
1.81M 4.94M 9.94M 13.14M
Total Current Liabilities
25.62M 45.53M 32.43M 33.18M
Long-Term Debt
n/a n/a 28.19M 27.89M
Other Long-Term Liabilities
559K 714K 1.64M 2.47M
Total Long-Term Liabilities
4.58M 5.33M 34M 46.52M
Total Liabilities
30.21M 50.87M 66.43M 79.7M
Total Debt
5.53M 26.28M 33.47M 33.47M
Common Stock
76K 73K 54K 46K
Retained Earnings
-378.39M -381.55M -389.86M -374.93M
Comprehensive Income
n/a n/a n/a 0.00
Shareholders Equity
43.21M 33.57M -10.64M -6.04M
Total Investments
15.07M 20.93M 5.07M 38.98M